global-alert
global messaging alerts
Simple. Reliable. Resilient.

Simple.
Reliable.
Resilient.

BFS Card
ApiJect Platform Uses Only Two Raw Materials

ApiJect Platform Uses Only
Two Raw Materials

Blow-Fill-Seal Uses a Compact Supply Chain

BFS Primary & Secondary Packaging in One Facility

BFS Primary & Secondary Packaging in One Facility

BFS Manufacturing/Secondary Packaging Line Infographic

previous arrow
next arrow

Compared to more traditional sterile liquid fill-finish formats, the ApiJect Platform has designed simplicity and reliability into its material procurement and production supply chain.

Simplified Material Procurement

Blow-Fill-Seal (BFS) prefilled drug delivery systems designed on the ApiJect Platform require only two primary materials: pharmaceutical-grade resins (LDPE and PP) and cannula.

  • Both materials can typically be sourced in all major markets.
  • BFS low-density polyethylene containers have very limited delamination issues.
  • Secondary packaging materials are generally available in all major markets.
  • In case of localized supply concerns, Needle Hubs and resin can potentially be stockpiled at manufacturing facilities

Highly Compact End-to-End Supply Chain

  • All BFS primary and secondary packaging can be done in 1-2 facilities.
  • Needle Hubs for Prefilled ApiJect Injector* are manufactured in a single facility.
  • A BFS filling line requires as little as 500 sq. ft. of ISO-7 space.
  • Kitting of BFS containers and attachable components can be done in the same facility as secondary packaging.

Highly Compact End-to-End Supply Chain

  • Once a mold is installed and the line is qualified, a BFS machine can scale-up reliably and quickly.
  • Needle hub manufacturing for Prefilled ApiJect Injectors* is done by Tae-Change Industrial™ of South Korea, the world’s second largest cannula supplier by volume.
  • A BFS filling line only requires approx. 500 sq. ft. of ISO-7 space.
  • ApiJect pre-set modular manufacturing units fulfills response for local, regional and international sterile manufacturing needs.
  • BFS containers are resistant to breakage or shattering, making them a very robust option for distribution and warehousing in all markets.
  • Kitting of the BFS containers and attachable components can be done in the same facility as the BFS manufacturing (today it is done in a separate facility).

*The Prefilled ApiJect Injector and its components are not cleared by the FDA or other regulatory bodies.

To learn more about the ApiJect Platform’s supply chain, contact Sr. Director of Supply Chain, Josh Myers.

random footer image
Social media & sharing icons powered by UltimatelySocial
Twitter
YouTube
YouTube
LinkedIn
LinkedIn